Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Lactoferrin in Biomedical Applications"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: 10 May 2023 | Viewed by 11588
Special Issue Editors
Interests: human microbiota and diseases; intracellular facultative bacteria; antiviral/antibacterial action of lactoferrin
Interests: lactoferrin; lactoferrin structure and funtions; in vitro and in vivo bacterial infections; in vitro and in vivo viral infections; inflammation; iron and inflammatory homeostasis disorders
Interests: lactoferrin; lactoferrin structure and funtions, in vitro and in vivo bacterial infections; in vitro and in vivo viral infections; inflammation; iron and inflammatory homeostasis
Special Issue Information
Lactoferrin (Lf), an iron-binding multifunctional cationic glycoprotein secreted by exocrine glands and neutrophils, is a bridge between natural and adaptative immunity. Bovine Lf (bLf) has been commercialized as nutraceutical product, having been declared as a compound “Generally Recognized as Safe” by the FDA and as a dietary supplement by EFSA.
This Special Issue aims to highlight some of the most significant contributions to the biomedical applications of Lf derived from different species, including bLf, which has been applied both in vitro and in vivo.
The topics of interest include (but are not limited to) Lf applications against microbial infections, iron and inflammatory homeostasis disorders, as well as immunomodulatory, antioxidant, and anticancer activities, with particular focus on the physicochemical characterization of Lf. The Lf receptors and the relationship between Lf and microbiota are pivotal for mechanisms of action. The development of new technologies that aim to improve its bioavailability should be considered. Original papers and review articles on Lf functions are welcome.
Dr. Maria Pia Conte
Prof. Dr. Piera Valenti
Dr. Luigi Rosa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lactoferrin physicochemical characterization
- lactoferrin receptors
- lactoferrin and microbiota
- bacterial activity
- viral activity
- iron homeostasis
- lactoferrin bioavailability